Watch TVGNW. Know when insiders buy.
One email the day a filing lands. Free.
TVGNW
Tevogen Inc.
No price history available
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
50
WATCH · shorts 50
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP —P/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$21.6MNET CASH —52W —SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$5.7M | −$5.8M | — | -1.52 | −$3M | — | — | Aug 14 |
| Q1 2026 · Mar 31 | — | — | — | −$5.4M | −$5.4M | — | -1.61 | −$2.7M | — | — | Aug 14 |
| Q4 2025 · Dec 31derived | — | — | — | −$4.6M | −$4.7M | — | -7.96 | −$2.2M | — | — | Mar 31 |
| Q3 2025 · Sep 30 | — | — | — | −$5.7M | −$5.7M | — | -0.03 | −$3.6M | — | — | Nov 14 |
| Q2 2025 · Jun 30 | — | — | — | −$5.4M | −$5.5M | — | -1.71 | −$3.2M | — | — | Aug 14 |
| Q1 2025 · Mar 31 | — | — | — | −$10.4M | −$10.4M | −192.0% | -3.25 | −$3.3M | — | — | Aug 14 |
| Q4 2024 · Dec 31derived | — | — | — | −$9.4M | −$9.4M | — | -3.49 | −$3M | — | — | Mar 31 |
| Q3 2024 · Sep 30 | — | — | — | −$6.1M | −$5.9M | — | -0.03 | −$3.8M | — | — | Nov 14 |
| Q2 2024 · Jun 30 | — | — | — | −$8.6M | −$9.7M | — | -0.04 | −$3M | — | — | Nov 14 |
| Q1 2024 · Mar 31 | — | — | — | −$29.5M | $11.3M | — | -0.26 | −$2.2M | — | — | Nov 14 |
| Q4 2023 · Dec 31derived | — | — | — | −$2M | −$3.6M | — | -0.14 | −$2M | $0 | −$2M | Apr 2 |
| Q3 2023 · Sep 30 | — | — | — | −$2.3M | −$3.9M | — | -0.03 | −$1.8M | $0 | −$1.8M | Nov 19 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$26.1M | −$26.3M | — | -8.08 | −$12.3M | $64K | −$12.4M | — | — |
| FY2024 · to Dec 31 | — | — | −$53.6M | −$13.7M | — | -3.50 | −$12M | — | — | — | — |
| FY2023 · to Dec 31 | — | — | −$8.8M | −$60.5M | — | -2.44 | −$8.2M | $133K | −$8.3M | $343M | — |
| FY2022 · to Dec 31 | — | — | — | $4.4M | — | — | −$215K | — | — | — | — |
Every number comes from Tevogen Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.